<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2023-02-23T17:58:42Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6121900" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6121900</identifier>
        <datestamp>2018-09-07</datestamp>
        <setSpec>ijms</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
              <journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
              <journal-id journal-id-type="publisher-id">ijms</journal-id>
              <journal-title-group>
                <journal-title>International Journal of Molecular Sciences</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1422-0067</issn>
              <publisher>
                <publisher-name>MDPI</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6121900</article-id>
              <article-id pub-id-type="pmcid">PMC6121900</article-id>
              <article-id pub-id-type="pmc-uid">6121900</article-id>
              <article-id pub-id-type="pmid">30071661</article-id>
              <article-id pub-id-type="doi">10.3390/ijms19082257</article-id>
              <article-id pub-id-type="publisher-id">ijms-19-02257</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Semantic Analysis of Posttranslational Modification of Proteins Accumulated in Thyroid Cancer Cells Exposed to Simulated Microgravity</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bauer</surname>
                    <given-names>Johann</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1-ijms-19-02257">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wehland</surname>
                    <given-names>Markus</given-names>
                  </name>
                  <xref ref-type="aff" rid="af2-ijms-19-02257">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Infanger</surname>
                    <given-names>Manfred</given-names>
                  </name>
                  <xref ref-type="aff" rid="af2-ijms-19-02257">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Grimm</surname>
                    <given-names>Daniela</given-names>
                  </name>
                  <xref ref-type="aff" rid="af2-ijms-19-02257">2</xref>
                  <xref ref-type="aff" rid="af3-ijms-19-02257">3</xref>
                  <xref rid="c1-ijms-19-02257" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2921-4454</contrib-id>
                  <name>
                    <surname>Gombocz</surname>
                    <given-names>Erich</given-names>
                  </name>
                  <xref ref-type="aff" rid="af4-ijms-19-02257">4</xref>
                </contrib>
              </contrib-group>
              <aff id="af1-ijms-19-02257"><label>1</label>Max-Planck-Institute for Biochemistry, 82152 Martinsried, Germany; <email>jbauer@biochem.mpg.de</email></aff>
              <aff id="af2-ijms-19-02257"><label>2</label>Clinic and Policlinic for Plastic, Aesthetic and Hand Surgery, Otto-von-Guericke-University, 39120 Magdeburg, Germany; <email>markus.wehland@med.ovgu.de</email> (M.W.); <email>manfred.infanger@med.ovgu.de</email> (M.I.)</aff>
              <aff id="af3-ijms-19-02257"><label>3</label>Department of Biomedicine, Aarhus University, Aarhus C 8000, Denmark</aff>
              <aff id="af4-ijms-19-02257"><label>4</label>Melissa Informatics, 2550 Ninth Street, Suite 114, Berkeley, CA, USA; <email>egombocz@ix.netcom.com</email></aff>
              <author-notes>
                <corresp id="c1-ijms-19-02257"><label>*</label>Correspondence: <email>dgg@biomed.au.dk</email>; Tel.: +45-8716-7693; Fax: +45-8612-8804</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>01</day>
                <month>8</month>
                <year>2018</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>8</month>
                <year>2018</year>
              </pub-date>
              <volume>19</volume>
              <issue>8</issue>
              <elocation-id>2257</elocation-id>
              <history>
                <date date-type="received">
                  <day>29</day>
                  <month>6</month>
                  <year>2018</year>
                </date>
                <date date-type="accepted">
                  <day>30</day>
                  <month>7</month>
                  <year>2018</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2018 by the authors.</copyright-statement>
                <copyright-year>2018</copyright-year>
                <license license-type="open-access">
                  <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract>
                <p>When monolayers of tissue cancer cells of various origins are exposed to real or simulated microgravity, many cells leave the monolayer and assemble to three-dimensional (3D) aggregates (spheroids). In order to define the cellular machinery leading to this change in growth behavior of FTC-133 human thyroid cancer cells and MCF-7 breast cancer cells, we recently performed proteome analyses on these cell lines and determined the proteins’ accumulation in monolayer cells grown under 1<italic>g</italic>-conditions as well as in the cells of spheroids assembled under simulated microgravity during three and 14 days, respectively. At that time, an influence of the increment or decrement of some of the more than 5000 proteins detected in each cell line was investigated. In this study, we focused on posttranslational modifications (PTMs) of proteins. For this purpose, we selected candidates from the list of the proteins detected in the two preceding proteome analyses, which showed significant accumulation in spheroid cells as compared to 1<italic>g</italic> monolayer cells. Then we searched for those PTMs of the selected proteins, which according to the literature have already been determined experimentally. Using the Semantic Protocol and RDF Query Language (SPARQL), various databases were examined. Most efficient was the search in the latest version of the dbPTM database. In total, we found 72 different classes of PTMs comprising mainly phosphorylation, glycosylation, ubiquitination and acetylation. Most interestingly, in 35 of the 69 proteins, N6 residues of lysine are modifiable.</p>
              </abstract>
              <kwd-group>
                <kwd>mass spectrometry</kwd>
                <kwd>Knowledge Explorer</kwd>
                <kwd>Reactome</kwd>
                <kwd>pathway analysis</kwd>
                <kwd>random positioning machine</kwd>
                <kwd>semantic network</kwd>
                <kwd>SPARQL reasoning</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec id="sec1-ijms-19-02257">
              <title>1. Introduction</title>
              <p>The occurrence of thyroid cancer is rising, especially among women. Worldwide, this tumor has become the seventh most common cancer among women [<xref rid="B1-ijms-19-02257" ref-type="bibr">1</xref>,<xref rid="B2-ijms-19-02257" ref-type="bibr">2</xref>]. If the progress of this cancer is driven by differentiated epithelial cells, it can frequently be cured [<xref rid="B3-ijms-19-02257" ref-type="bibr">3</xref>]. Poorly differentiated or anaplastic types of thyroid cancer, however, have an unfavorable prognosis and current therapy options are limited [<xref rid="B4-ijms-19-02257" ref-type="bibr">4</xref>,<xref rid="B5-ijms-19-02257" ref-type="bibr">5</xref>]. Therefore, new strategies have been investigated in order to find novel targets for therapy of this kind of tumor [<xref rid="B6-ijms-19-02257" ref-type="bibr">6</xref>] and to prevent metastasis [<xref rid="B7-ijms-19-02257" ref-type="bibr">7</xref>]. </p>
              <p>For several years we have investigated the behavior of malignant thyroid cells, putting emphasis on cellular differentiation and on their migration [<xref rid="B8-ijms-19-02257" ref-type="bibr">8</xref>]. In this context, we exposed human follicular thyroid cancer cells to simulated and real microgravity (µ<italic>g</italic>) in vitro [<xref rid="B9-ijms-19-02257" ref-type="bibr">9</xref>]. Under this condition, a part of the cells leaves the two-dimensional (2D) monolayers. Normally, thyroid cancer cells grow adherently in a 2D layer in vitro when they are seeded in culture flasks and incubated in an incubator on Earth at 1<italic>g</italic> normal laboratory conditions. The cells leaving monolayers assemble scaffold-free into three-dimensional (3D) aggregates (so-called spheroids) and continue to grow there [<xref rid="B10-ijms-19-02257" ref-type="bibr">10</xref>]. This change of phenotype happens during spaceflights, as well as during cell cultivation on devices preventing sedimentation by annulling or randomization of the gravity vector [<xref rid="B10-ijms-19-02257" ref-type="bibr">10</xref>,<xref rid="B11-ijms-19-02257" ref-type="bibr">11</xref>,<xref rid="B12-ijms-19-02257" ref-type="bibr">12</xref>,<xref rid="B13-ijms-19-02257" ref-type="bibr">13</xref>,<xref rid="B14-ijms-19-02257" ref-type="bibr">14</xref>]. It is accompanied by structural changes of the cytoskeleton as well as by alterations of the mRNA expression pattern and the protein production [<xref rid="B15-ijms-19-02257" ref-type="bibr">15</xref>,<xref rid="B16-ijms-19-02257" ref-type="bibr">16</xref>,<xref rid="B17-ijms-19-02257" ref-type="bibr">17</xref>] and appears to mimic metastasis-like scaffold-supported cell migration [<xref rid="B18-ijms-19-02257" ref-type="bibr">18</xref>]. </p>
              <p>Mass spectrometry is a powerful method to analyze the protein production of human cells [<xref rid="B19-ijms-19-02257" ref-type="bibr">19</xref>]. It currently is applied in many fields including space research [<xref rid="B20-ijms-19-02257" ref-type="bibr">20</xref>,<xref rid="B21-ijms-19-02257" ref-type="bibr">21</xref>,<xref rid="B22-ijms-19-02257" ref-type="bibr">22</xref>]. Recently, we performed deep proteome analyses on thyroid cancer cells unveiling about 5900 proteins, and on MCF-7 breast cancer cells for comparison, aiming to shed light on the molecular machinery, which enables the cells to move from one kind of growth (monolayer) to another one (spheroid) [<xref rid="B17-ijms-19-02257" ref-type="bibr">17</xref>,<xref rid="B23-ijms-19-02257" ref-type="bibr">23</xref>]. The studies revealed a number of proteins, whose accumulations were significantly different, when they were found either in monolayer cells of normal 1<italic>g</italic> cultures or in spheroids formed under simulated microgravity. Taken together they suggested that there is a relationship between the increment and decrement of distinct proteins and the kind of growth of the cells [<xref rid="B17-ijms-19-02257" ref-type="bibr">17</xref>,<xref rid="B23-ijms-19-02257" ref-type="bibr">23</xref>]. Furthermore, we observed phosphorylation of profilin-2 and de-phosphorylation of extracellular signal–regulated kinases (ERKs) 1/2 on thyroid cells exposed to microgravity [<xref rid="B24-ijms-19-02257" ref-type="bibr">24</xref>,<xref rid="B25-ijms-19-02257" ref-type="bibr">25</xref>] and recognized that genes mostly up- and down-regulated during a ten-day space mission coded for enzymes involved in posttranslational modifications (PTM) of target proteins [<xref rid="B26-ijms-19-02257" ref-type="bibr">26</xref>]. The observations are in accordance with publications of other researchers [<xref rid="B27-ijms-19-02257" ref-type="bibr">27</xref>,<xref rid="B28-ijms-19-02257" ref-type="bibr">28</xref>]. Hence, it is probable that a protein’s activation status determined by PTM, such as phosphorylation, glycosylation, ubiquitination and others [<xref rid="B29-ijms-19-02257" ref-type="bibr">29</xref>,<xref rid="B30-ijms-19-02257" ref-type="bibr">30</xref>], is also important for the cellular behavior under µ<italic>g</italic>.</p>
              <p>Consequently, we intend to gain comprehensive information about PTMs, which occur in thyroid cells forming a spheroid. We expect various PTMs to occur in a tremendous number of proteins [<xref rid="B31-ijms-19-02257" ref-type="bibr">31</xref>,<xref rid="B32-ijms-19-02257" ref-type="bibr">32</xref>], which appear to be involved in the cells leaving a monolayer and joining a 3D aggregate. Hence, we assume that a high number of experiments will be required until a reasonable overview will be obtained. In order to keep this number as low as possible, in this study we try to find PTMs that, according to the literature, have already been observed on proteins involved in spheroid formation. </p>
              <p>PTMs already noticed by experiments are stored in various public repositories including the newly extended comprehensive dbPTM database [<xref rid="B33-ijms-19-02257" ref-type="bibr">33</xref>]. Using Semantic Protocol and RDF Query Language (SPARQL) endpoints and a semantic data model allows the retrieval and handling of data stored in Resource Description Framework (RDF) format for further interlinking of various databases and enrichment of information through inference queries. In order to accomplish this, we applied the Sentient Knowledge Explorer (KE), semantic retrieval software that enables mapping, aligning and merging of information from several relevant resources [<xref rid="B34-ijms-19-02257" ref-type="bibr">34</xref>,<xref rid="B35-ijms-19-02257" ref-type="bibr">35</xref>], to establish the most comprehensive evidence possible. </p>
            </sec>
            <sec id="sec2-ijms-19-02257">
              <title>2. Results and Discussion</title>
              <sec id="sec2dot1-ijms-19-02257">
                <title>2.1. Selection of Proteins from a Set of Data Obtained in a Preceding Mass Spectrometry (MS) Analysis</title>
                <p>69 proteins of interest (<xref rid="ijms-19-02257-t001" ref-type="table">Table 1</xref>) were selected from a list of 5989 human thyroid proteins identified and quantified in a recent proteome study on FTC-133 thyroid cancer cells, which grew in a monolayer under normal 1<italic>g</italic> laboratory conditions or within spheroids exposed to a random positioning machine (RPM) simulating microgravity during three days of incubation [<xref rid="B17-ijms-19-02257" ref-type="bibr">17</xref>]. These proteins were of interest because they were found in spheroid cells but not in control monolayer cells, or were found in spheroid cells at a 1.8-fold higher accumulation than in control cells. In addition, they also were detected by a second independent proteome analysis on MCF-7 breast cancer cells, which grew in a monolayer under normal 1<italic>g</italic> laboratory conditions or within spheroids exposed to an RPM for 14 days [<xref rid="B23-ijms-19-02257" ref-type="bibr">23</xref>]. Their up-regulation in spheroid cells as compared to control cells was similar to those of the corresponding FTC-133 cells (<xref rid="ijms-19-02257-t001" ref-type="table">Table 1</xref>). The selected 69 proteins comprised 1.2% of the total proteins detected in the FTC-133 spheroid cells. Since each of these proteins was detected in at least four samples being accumulated in spheroids of FTC-133 cells after three days and in MCF-7 spheroids after 14 days, they were considered to be candidates for triggering a transition from a 2D to a 3D kind of growth. In order to prove this hypothesis, they were further analyzed applying in silico methods.</p>
              </sec>
              <sec id="sec2dot2-ijms-19-02257">
                <title>2.2. Characterization of the Selected 69 Proteins According to Localization and Interaction</title>
                <p>In a first approach, the cellular location of the selected proteins was studied using the Elsevier Pathway Studio v11 (Elsevier, Amsterdam, the Netherlands). <xref ref-type="fig" rid="ijms-19-02257-f001">Figure 1</xref> shows that the majority of these proteins are located within the cytoplasm. But others are active within the nucleus, the mitochondria, the endoplasmic reticulum ER, the membrane and the extracellular matrix. At that point, it was of interest to see whether the selected proteins represent single independent hits or are members of a network. The Pathway Studio analysis revealed that 20 of these proteins form a network of interaction either on a gene level or on a protein level. Central components of the network were heme oxygenase 1 (<italic>HMOX1</italic>), thioredoxin (<italic>TXN</italic>) and NAD(P)H dehydrogenase [quinone] 1 (<italic>NQO1</italic>) (<xref ref-type="fig" rid="ijms-19-02257-f001">Figure 1</xref>). HMOX1 and NQO1 are both regulated by the transcription factor Nrf2 [<xref rid="B36-ijms-19-02257" ref-type="bibr">36</xref>]. HMOX1 was of special interest because it had already shown up in an earlier study and was considered as important for spheroid formation [<xref rid="B37-ijms-19-02257" ref-type="bibr">37</xref>]. In addition to the interactions shown in <xref ref-type="fig" rid="ijms-19-02257-f001">Figure 1</xref>, it has relationships to nuclear factor kappa B [<xref rid="B25-ijms-19-02257" ref-type="bibr">25</xref>], to connective tissue growth factor, caveolin 1, and to intercellular adhesion molecule 1. All these proteins were found in earlier studies and were considered as key proteins of spheroid formation [<xref rid="B24-ijms-19-02257" ref-type="bibr">24</xref>,<xref rid="B38-ijms-19-02257" ref-type="bibr">38</xref>,<xref rid="B39-ijms-19-02257" ref-type="bibr">39</xref>]. </p>
              </sec>
              <sec id="sec2dot3-ijms-19-02257">
                <title>2.3. Creation of a Semantic Knowledge Base on PTM Modification</title>
                <p>Regarding the 69 proteins shown in <xref rid="ijms-19-02257-t001" ref-type="table">Table 1</xref>, which were selected due to their differences of accumulation in monolayer cells exposed to gravity as compared to spheroids cultured under microgravity, we were not only interested in cellular localization and interaction. We also focused on their posttranslational modifications, which generally have a great influence on cellular behavior [<xref rid="B29-ijms-19-02257" ref-type="bibr">29</xref>,<xref rid="B30-ijms-19-02257" ref-type="bibr">30</xref>]. Since a great number of PTMs could theoretically be considered for the selected 69 proteins, we retrieved only PTMs that, according to the literature, have already been verified for these proteins experimentally, and tried to set up a relationship to their function and their influence on the behavior of the cells. In order to find relevant literature and information about the proteins’ PTMs, we applied the KE, which enables searching of various databases for many PTMs and harmonization of the results. Databases searched included UniProt, Entrez, Reactome and dbPTM (<xref ref-type="fig" rid="ijms-19-02257-f002">Figure 2</xref>). These databases contain information supplementing each other, so that not only PTMs can be found but also their role within the concert of life.</p>
                <p>Using KE, relevant information about each of the 69 proteins was collected from UniProt in a first step. For this purpose, a spreadsheet was created containing the names of the 69 proteins selected together with their gene names, UniProt accession numbers and experimental data, which indicated the individual cellular accumulation by LfQ scores (<xref rid="ijms-19-02257-t001" ref-type="table">Table 1</xref>). </p>
                <p>To build the initial Semantic Knowledge Base (SKB), the spreadsheet was imported into KE and mapping of the experimental data based on their protein accession numbers to UniProt’s SPARQL endpoint was applied [<xref rid="B41-ijms-19-02257" ref-type="bibr">41</xref>]. A representative starting network for two selected proteins (Heme oxygenase 1 and NAD(P)H dehydrogenase [quinone] 1) from the 69 proteins of specific interest is shown in <xref ref-type="fig" rid="ijms-19-02257-f003">Figure 3</xref>.</p>
                <p>In the next step, SPARQL queries were developed by selecting nodes from the canvas of the network graphs and applying filters via setting a certain element’s variable or by applying restrictions, such as ranges on numerical values, as described earlier [<xref rid="B34-ijms-19-02257" ref-type="bibr">34</xref>,<xref rid="B35-ijms-19-02257" ref-type="bibr">35</xref>]. They were translated to text queries by KE. After suitable formulation they could be used to access a number of databases. First, a query was formulated suitable to search selected U.S. National Library of Medicine (NLM) databases (Biosystems, Protein, Gene, Online Mendelian Inheritance in Man (OMIM), Single Nucleotide Polymorphisms (SNP)). Then the National Center for Biotechnology Information (NCBI) Entrez Application Programming Interface (API) Connector was used to import results from the SPARQL queries directly as RDF into the knowledge graph [<xref rid="B42-ijms-19-02257" ref-type="bibr">42</xref>,<xref rid="B43-ijms-19-02257" ref-type="bibr">43</xref>]. The information obtained augments the characterization of a selected protein and will help to relate PTMs to their biological processes and the signaling pathways involved. This is shown for heme oxygenase in regard to functional, genetic and biological aspects of human thyroid cells (<xref ref-type="fig" rid="ijms-19-02257-f004">Figure 4</xref>). The information was mainly included in literature references indicated by PubMed unique identifier (PMID) numbers.</p>
                <p>Subsequently, further SPARQL queries were used to expand the SKB by importing the protein’s involvement in signaling pathways from Reactome [<xref rid="B44-ijms-19-02257" ref-type="bibr">44</xref>], after cross reference with pathway information stored in the Kyoto Encyclopedia of Genes and Genomes (KEGG). In the lower part of <xref ref-type="fig" rid="ijms-19-02257-f004">Figure 4</xref>, the pathways found for heme oxygenase are indicated by black arrows to brown blocks. The numbers R-HAS-917937 and R-HAS-6785807 point to pathways of iron uptake and transportation, and of interleukin 4 signaling, respectively.</p>
                <p>In a final step, PTM information about the proteins selected was retrieved [<xref rid="B29-ijms-19-02257" ref-type="bibr">29</xref>]. For this purpose, a SPARQL query was formulated to search the database dbPTM [<xref rid="B33-ijms-19-02257" ref-type="bibr">33</xref>]. The query contains information obtained from UniProt and directs the program to search PTMs in the dbPTM database for all proteins imported into KE via spreadsheet (<xref ref-type="fig" rid="ijms-19-02257-f005">Figure 5</xref>, <xref rid="ijms-19-02257-t001" ref-type="table">Table 1</xref>). In the database, those fields were searched where information about the reference source, the type of a modification and the location with a short segment of the sequence modified can be found. In addition, the size of the area covered by the modification is available.</p>
                <p>Iterative use of queries with filters for the parameters of interest enabled us to accumulate comprehensive information about the PTMs of 69 proteins (see <xref ref-type="app" rid="app1-ijms-19-02257">Supplementary Table S1</xref>). <xref ref-type="fig" rid="ijms-19-02257-f006">Figure 6</xref> shows PTMs (yellow-green boxes) for 23 proteins (icons with accession numbers) selected from the total 69 proteins in order to keep a clear view on details. It can be seen that there are proteins with many PTMs and others with only a few or one. For example, cofilin-1, with the accession number P23528, shows arrows to a considerable number of PTMs, while the Ras-related protein, Rab-27B (O00194), shows only one arrow which links the icon to an <italic>N</italic>-acetylation of threonine. Taken together, it is obvious that the selected proteins are frequently modified by phosphorylation, ubiquitination and glycosylation. </p>
              </sec>
              <sec id="sec2dot4-ijms-19-02257">
                <title>2.4. Analysis of the SKB on PTM Modification</title>
                <p>The knowledge base created for 69 proteins is rather complex if it is represented as shown in <xref ref-type="fig" rid="ijms-19-02257-f006">Figure 6</xref>. Looking at such diagrams, recognizing detailed and useful information visually is difficult. Hence, the complexity was reduced by splitting the whole knowledge base into segments and visualizing and highlighting the results in individual graphs. For this purpose, graphical queries were applied to the entire network and their results highlighted. The aggregated query results are exported as spreadsheets to create final tables for all proteins involved in the study. <xref rid="ijms-19-02257-t002" ref-type="table">Table 2</xref> shows detailed data about five exemplary proteins. </p>
                <p>A summary of PTMs found for all of the 69 proteins is provided in the <xref ref-type="app" rid="app1-ijms-19-02257">Supplementary Table S1</xref>, which shows the substrate sites already proved experimentally, but not sites theoretically modifiable, and indicates the accessible surface areas (ASA) covered by the modification. An evaluation of the table reveals 72 different classes of identified PTMs. In total, 406 classified PTMs have been counted as single count/protein for a specific class, even when multiple sites/protein have been affected. Of these, the most prominent classes were phosphorylation (48%; phosphoserine, phosphotyrosine, phosphothreonine) and lysine-N6 modification (18.9%), followed by modifications of other residual nitrogens (12.8%) or sulfurs (4%), and by glycin-lysin dipeptide coupling (3.4%). It should also be mentioned that 35 of the 69 proteins were modified on N6 groups of lysine. This observation is of great interest, because a tremendous down-regulation of the gene of the protein-lysine 6-oxidase (<italic>LOX</italic>) has been observed in FTC-133 cells during the Shenzhou-8/SimBox space mission [<xref rid="B16-ijms-19-02257" ref-type="bibr">16</xref>,<xref rid="B26-ijms-19-02257" ref-type="bibr">26</xref>]. The protein-lysine 6-oxidase catalyzes deamination of lysine residues [<xref rid="B45-ijms-19-02257" ref-type="bibr">45</xref>]. </p>
              </sec>
            </sec>
            <sec id="sec3-ijms-19-02257">
              <title>3. Conclusions</title>
              <p>Proteins change their influence on the life of a cell when differently accumulated within the cells and when modified after their translation. A comparative proteome analysis of thyroid cancer cells living within a monolayer under normal gravity or within spheroids under simulated µg, showed an up-regulation of 69 proteins detected in spheroids. Applying the KE, we searched in databases containing relevant literature and biological pathways. Most efficient was searching the dbPTM databases, which triplicated the result (<xref ref-type="app" rid="app1-ijms-19-02257">Supplementary Table S1</xref>). Hence, we learnt details about the PTMs of each of the 69 proteins (<xref rid="ijms-19-02257-t002" ref-type="table">Table 2</xref>, <xref ref-type="app" rid="app1-ijms-19-02257">Supplementary Table S1</xref>). Their evaluation unveiled a high percentage of the 69 selected proteins with modifiable N6 lysine residues. Hence, the study shows a way to facilitate planning work on possible PTMs of proteins of cells actually changing their type of growth and offers an explanation of earlier findings regarding the <italic>LOX</italic> gene. In future, the method may complement even advanced methods of proteome analysis with PTM identification facilities [<xref rid="B46-ijms-19-02257" ref-type="bibr">46</xref>].</p>
            </sec>
            <sec id="sec4-ijms-19-02257">
              <title>4. Materials and Methods</title>
              <sec id="sec4dot1-ijms-19-02257">
                <title>4.1. Proteome Data Used</title>
                <p>The proteins were obtained by mass spectrometry from FTC-133 human follicular thyroid carcinoma cells and from MCF-7 human breast adenocarcinoma cells according to protocols described in refs. [<xref rid="B17-ijms-19-02257" ref-type="bibr">17</xref>,<xref rid="B23-ijms-19-02257" ref-type="bibr">23</xref>]. Prior to analysis both types of cells had been grown either within a monolayer under normal 1<italic>g</italic> laboratory conditions or within spheroids exposed to an RPM [<xref rid="B10-ijms-19-02257" ref-type="bibr">10</xref>]. After harvest, the cells were lysed and subjected to mass spectrometry, obeying the protocols described in refs. [<xref rid="B17-ijms-19-02257" ref-type="bibr">17</xref>,<xref rid="B23-ijms-19-02257" ref-type="bibr">23</xref>,<xref rid="B47-ijms-19-02257" ref-type="bibr">47</xref>,<xref rid="B48-ijms-19-02257" ref-type="bibr">48</xref>]. Finally, raw data from the mass spectrometer were processed using MaxQuant (May Planck Society, Munich, Germany) computational proteomics platform (version 1.5.2.22) [<xref rid="B49-ijms-19-02257" ref-type="bibr">49</xref>] using the standard parameters. Relative protein concentration was performed using the LfQ algorithm (label free quantitation) as described in [<xref rid="B50-ijms-19-02257" ref-type="bibr">50</xref>].</p>
              </sec>
              <sec id="sec4dot2-ijms-19-02257">
                <title>4.2. Pathway Analysis</title>
                <p>To investigate and visualize the original localization and the mutual interactions of detected proteins, we entered relevant UniProt accession numbers in a Pathway Studio v.11 software (Elsevier Research Solutions, Amsterdam, The Netherlands) [<xref rid="B17-ijms-19-02257" ref-type="bibr">17</xref>,<xref rid="B23-ijms-19-02257" ref-type="bibr">23</xref>]. </p>
              </sec>
              <sec id="sec4dot3-ijms-19-02257">
                <title>4.3. Application of the Knowledge Explorer</title>
                <p>To create a semantic network, harmonize content from multiple resources, and allow for graphical querying and reasoning, experimental data were imported to establish an initial RDF knowledge base using Sentient Knowledge Explorer (Melissa Informatics, Berkeley, CA, USA—former IO Informatics) [<xref rid="B34-ijms-19-02257" ref-type="bibr">34</xref>]. The workflow of the process to generate a knowledge base by iterative selective SPARQL queries with reasoning to those resources and importing their results into the semantic network is depicted in <xref ref-type="fig" rid="ijms-19-02257-f002">Figure 2</xref>. UniProt content was queried using its SPARQL endpoint to augment information on enzymes and reported protein functions [<xref rid="B41-ijms-19-02257" ref-type="bibr">41</xref>]. The Entrez resources Gene, OMIM, Protein, PubMed and SNP were used via Knowledge Explorer’s NCBI Connector services to add content [<xref rid="B42-ijms-19-02257" ref-type="bibr">42</xref>,<xref rid="B43-ijms-19-02257" ref-type="bibr">43</xref>,<xref rid="B51-ijms-19-02257" ref-type="bibr">51</xref>]. Parts of KEGG and Reactome were used to validate pathway information [<xref rid="B44-ijms-19-02257" ref-type="bibr">44</xref>]. For classification of post translational modifications, the integrated resource for protein Post-Translational Modifications (dbPTM) was used [<xref rid="B52-ijms-19-02257" ref-type="bibr">52</xref>]. The dbPTM is an integrated resource for protein post-translational modifications experimentally verified and annotating the potential PTMs for all UniProtKB protein entries [<xref rid="B53-ijms-19-02257" ref-type="bibr">53</xref>]. dbPTM [<xref rid="B33-ijms-19-02257" ref-type="bibr">33</xref>,<xref rid="B53-ijms-19-02257" ref-type="bibr">53</xref>] is an aggregated protein-modification and protein-interaction database containing data from 7 sources (Uniprot, HPRB, PhosphoELM, Phosphositeplus, SysPTM [<xref rid="B54-ijms-19-02257" ref-type="bibr">54</xref>], dbSNO [<xref rid="B55-ijms-19-02257" ref-type="bibr">55</xref>], MeMo [<xref rid="B56-ijms-19-02257" ref-type="bibr">56</xref>]), which categorize more than 80 classes of posttranslational modifications. It integrates experimentally verified PTMs from several databases and annotates the potential PTMs for all UniProtKB protein entries. Since the last update, dbPTM also provides disease association based on non-synonymous single nucleotide polymorphisms (nsSNPs). All PTMs experimentally confirmed for each protein were collected and denoted according to their PTM classification. The records were added to establish the final comprehensive SKB. </p>
              </sec>
            </sec>
          </body>
          <back>
            <ack>
              <title>Acknowledgments</title>
              <p>The authors would like to thank Nagarjuna Nagaraj, PhD, Core facility for mass spectrometry and proteomics, Max-Planck Institute for Biochemistry, Martinsried, Germany for performing the MS experiments. The authors also would like to thank Jerven Bolleman at the Swiss Institute of Bioinformatics (SIB) for his work on UniProt’s SPARQL endpoint.</p>
            </ack>
            <app-group>
              <app id="app1-ijms-19-02257">
                <title>Supplementary Materials</title>
                <p>The following are available online at <uri xlink:href="http://www.mdpi.com/1422-0067/19/8/2257/s1">http://www.mdpi.com/1422-0067/19/8/2257/s1</uri>.</p>
                <supplementary-material content-type="local-data" id="ijms-19-02257-s001">
                  <media xlink:href="ijms-19-02257-s001.zip">
                    <caption>
                      <p>Click here for additional data file.</p>
                    </caption>
                  </media>
                </supplementary-material>
              </app>
            </app-group>
            <notes>
              <title>Author Contributions</title>
              <p>J.B. evaluated the proteome analysis. J.B. and E.G. wrote the manuscript. M.W., M.I. and D.G. performed the cell culturing and R.P.M. experiments. E.G. provided the semantic integration, querying and reasoning over normalized public resources and the necessary network graphical representations for visual query and reporting. </p>
            </notes>
            <notes>
              <title>Funding</title>
              <p>This project was supported by the German Space Agency (DLR, grant 50WB1524).</p>
            </notes>
            <notes notes-type="COI-statement">
              <title>Conflicts of Interest</title>
              <p>The authors have declared no conflict of interest.</p>
            </notes>
            <glossary>
              <title>Abbreviations</title>
              <array orientation="portrait">
                <tbody>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">µ<italic>g</italic></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Microgravity</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">PTM(s)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Posttranslational modification(s)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">RPM</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Random Positioning Machine</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">LfQ</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">label free quantitation</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">SKB</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Semantic Knowledge Base</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">2D</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Two-dimensional</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">3D</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Three-dimensional</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">KE</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Knowledge Explorer</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">RDF</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Resource Description Framework</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">RPM</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Random positioning machine</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">SPARQL</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Semantic Protocol and RDF Query Language</td>
                  </tr>
                </tbody>
              </array>
            </glossary>
            <ref-list>
              <title>References</title>
              <ref id="B1-ijms-19-02257">
                <label>1.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <collab>American Cancer Society</collab>
                  </person-group>
                  <source>Global Cancer Facts &amp; Figures</source>
                  <edition>3rd ed.</edition>
                  <publisher-name>American Cancer Society</publisher-name>
                  <publisher-loc>Atlanta, GA, USA</publisher-loc>
                  <year>2015</year>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/global-cancer-facts-and-figures/global-cancer-facts-and-figures-3rd-edition.pdf">http://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/global-cancer-facts-and-figures/global-cancer-facts-and-figures-3rd-edition.pdf</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2017-07-17">(accessed on 17 July 2017)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B2-ijms-19-02257">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cabanillas</surname>
                      <given-names>M.E.</given-names>
                    </name>
                    <name>
                      <surname>McFadden</surname>
                      <given-names>D.G.</given-names>
                    </name>
                    <name>
                      <surname>Durante</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Thyroid cancer</article-title>
                  <source>Lancet</source>
                  <year>2016</year>
                  <volume>388</volume>
                  <fpage>2783</fpage>
                  <lpage>2795</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0140-6736(16)30172-6</pub-id>
                  <pub-id pub-id-type="pmid">27240885</pub-id>
                </element-citation>
              </ref>
              <ref id="B3-ijms-19-02257">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schmidbauer</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Menhart</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Hellwig</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Grosse</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Differentiated thyroid cancer-treatment: State of the art</article-title>
                  <source>Int. J. Mol. Sci.</source>
                  <year>2017</year>
                  <volume>18</volume>
                  <pub-id pub-id-type="doi">10.3390/ijms18061292</pub-id>
                  <?supplied-pmid 28629126?>
                  <pub-id pub-id-type="pmid">28629126</pub-id>
                </element-citation>
              </ref>
              <ref id="B4-ijms-19-02257">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ancker</surname>
                      <given-names>O.V.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>The adverse effect of hypertension in the treatment of thyroid cancer with multi-kinase inhibitors</article-title>
                  <source>Int. J. Mol. Sci.</source>
                  <year>2017</year>
                  <volume>18</volume>
                  <pub-id pub-id-type="doi">10.3390/ijms18030625</pub-id>
                  <?supplied-pmid 28335429?>
                  <pub-id pub-id-type="pmid">28335429</pub-id>
                </element-citation>
              </ref>
              <ref id="B5-ijms-19-02257">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sanders</surname>
                      <given-names>E.M.</given-names>
                      <suffix>Jr.</suffix>
                    </name>
                    <name>
                      <surname>LiVolsi</surname>
                      <given-names>V.A.</given-names>
                    </name>
                    <name>
                      <surname>Brierley</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Shin</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Randolph</surname>
                      <given-names>G.W.</given-names>
                    </name>
                  </person-group>
                  <article-title>An evidence-based review of poorly differentiated thyroid cancer</article-title>
                  <source>World J. Surg.</source>
                  <year>2007</year>
                  <volume>31</volume>
                  <fpage>934</fpage>
                  <lpage>945</lpage>
                  <?supplied-pmid 17431717?>
                  <pub-id pub-id-type="pmid">17431717</pub-id>
                </element-citation>
              </ref>
              <ref id="B6-ijms-19-02257">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Xing</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Braf mutation in papillary thyroid cancer: Pathogenic role, molecular bases, and clinical implications</article-title>
                  <source>Endocr. Rev.</source>
                  <year>2007</year>
                  <volume>28</volume>
                  <fpage>742</fpage>
                  <lpage>762</lpage>
                  <pub-id pub-id-type="doi">10.1210/er.2007-0007</pub-id>
                  <?supplied-pmid 17940185?>
                  <pub-id pub-id-type="pmid">17940185</pub-id>
                </element-citation>
              </ref>
              <ref id="B7-ijms-19-02257">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Are</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Shaha</surname>
                      <given-names>A.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Anaplastic thyroid carcinoma: Biology, pathogenesis, prognostic factors, and treatment approaches</article-title>
                  <source>Ann. Surg. Oncol.</source>
                  <year>2006</year>
                  <volume>13</volume>
                  <fpage>453</fpage>
                  <lpage>464</lpage>
                  <pub-id pub-id-type="doi">10.1245/ASO.2006.05.042</pub-id>
                  <?supplied-pmid 16474910?>
                  <pub-id pub-id-type="pmid">16474910</pub-id>
                </element-citation>
              </ref>
              <ref id="B8-ijms-19-02257">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schönberger</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Spruss</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Weber</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Chahoud</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Eilles</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Establishment and characterization of the follicular thyroid carcinoma cell line ML-1</article-title>
                  <source>J. Mol. Med.</source>
                  <year>2000</year>
                  <volume>78</volume>
                  <fpage>102</fpage>
                  <lpage>110</lpage>
                  <pub-id pub-id-type="doi">10.1007/s001090000085</pub-id>
                  <?supplied-pmid 10794546?>
                  <pub-id pub-id-type="pmid">10794546</pub-id>
                </element-citation>
              </ref>
              <ref id="B9-ijms-19-02257">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Egli</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Wise</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Ulbrich</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>The effects of weightlessness on the human organism and mammalian cells</article-title>
                  <source>Curr. Mol. Med.</source>
                  <year>2011</year>
                  <volume>11</volume>
                  <fpage>350</fpage>
                  <lpage>364</lpage>
                  <pub-id pub-id-type="doi">10.2174/156652411795976600</pub-id>
                  <?supplied-pmid 21568935?>
                  <pub-id pub-id-type="pmid">21568935</pub-id>
                </element-citation>
              </ref>
              <ref id="B10-ijms-19-02257">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Warnke</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Kopp</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Hemmersbach</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Thyroid cells exposed to simulated microgravity conditions—Comparison of the fast rotating clinostat and the random positioning machine</article-title>
                  <source>Microgravity Sci. Technol.</source>
                  <year>2016</year>
                  <volume>28</volume>
                  <fpage>247</fpage>
                  <lpage>260</lpage>
                  <pub-id pub-id-type="doi">10.1007/s12217-015-9456-7</pub-id>
                </element-citation>
              </ref>
              <ref id="B11-ijms-19-02257">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Aleshcheva</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Schwarzwälder</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Segerer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Birlem</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Horn</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Spheroid formation of human thyroid cancer cells in an automated culturing system during the shenzhou-8 space mission</article-title>
                  <source>Biomaterials</source>
                  <year>2013</year>
                  <volume>34</volume>
                  <fpage>7694</fpage>
                  <lpage>7705</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.06.054</pub-id>
                  <?supplied-pmid 23866977?>
                  <pub-id pub-id-type="pmid">23866977</pub-id>
                </element-citation>
              </ref>
              <ref id="B12-ijms-19-02257">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Borst</surname>
                      <given-names>A.G.</given-names>
                    </name>
                    <name>
                      <surname>van Loon</surname>
                      <given-names>J.J.W.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Technology and developments for the random positioning machine, rpm</article-title>
                  <source>Microgravity Sci. Technol.</source>
                  <year>2008</year>
                  <volume>21</volume>
                  <fpage>287</fpage>
                  <lpage>292</lpage>
                  <pub-id pub-id-type="doi">10.1007/s12217-008-9043-2</pub-id>
                </element-citation>
              </ref>
              <ref id="B13-ijms-19-02257">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hauslage</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Cevik</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Hemmersbach</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Pyrocystis noctiluca represents an excellent bioassay for shear forces induced in ground-based microgravity simulators (clinostat and random positioning machine)</article-title>
                  <source>NPJ Microgravity</source>
                  <year>2017</year>
                  <volume>3</volume>
                  <pub-id pub-id-type="doi">10.1038/s41526-017-0016-x</pub-id>
                  <?supplied-pmid 28649634?>
                  <pub-id pub-id-type="pmid">28649634</pub-id>
                </element-citation>
              </ref>
              <ref id="B14-ijms-19-02257">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wuest</surname>
                      <given-names>S.L.</given-names>
                    </name>
                    <name>
                      <surname>Richard</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Kopp</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Egli</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Simulated microgravity: Critical review on the use of random positioning machines for mammalian cell culture</article-title>
                  <source>Biomed Res. Int.</source>
                  <year>2015</year>
                  <volume>2015</volume>
                  <pub-id pub-id-type="doi">10.1155/2015/971474</pub-id>
                  <?supplied-pmid 25649075?>
                  <pub-id pub-id-type="pmid">25649075</pub-id>
                </element-citation>
              </ref>
              <ref id="B15-ijms-19-02257">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Kossmehl</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Shakibaei</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Kossmehl-Zorn</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Cogoli</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Curcio</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Oksche</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Kreutz</surname>
                      <given-names>R.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Simulated weightlessness changes the cytoskeleton and extracellular matrix proteins in papillary thyroid carcinoma cells</article-title>
                  <source>Cell Tissue Res.</source>
                  <year>2006</year>
                  <volume>324</volume>
                  <fpage>267</fpage>
                  <lpage>277</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00441-005-0142-8</pub-id>
                  <?supplied-pmid 16432709?>
                  <pub-id pub-id-type="pmid">16432709</pub-id>
                </element-citation>
              </ref>
              <ref id="B16-ijms-19-02257">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ma</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Schulz</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Saar</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Hubner</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Braun</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Schwarzwälder</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Segerer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Differential gene expression profile and altered cytokine secretion of thyroid cancer cells in space</article-title>
                  <source>FASEB J.</source>
                  <year>2014</year>
                  <volume>28</volume>
                  <fpage>813</fpage>
                  <lpage>835</lpage>
                  <pub-id pub-id-type="doi">10.1096/fj.13-243287</pub-id>
                  <?supplied-pmid 24196587?>
                  <pub-id pub-id-type="pmid">24196587</pub-id>
                </element-citation>
              </ref>
              <ref id="B17-ijms-19-02257">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Kopp</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Schlagberger</surname>
                      <given-names>E.M.</given-names>
                    </name>
                    <name>
                      <surname>Grosse</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Sahana</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Riwaldt</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Luetzenberg</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Proteome analysis of human follicular thyroid cancer cells exposed to the random positioning machine</article-title>
                  <source>Int. J. Mol. Sci.</source>
                  <year>2017</year>
                  <volume>18</volume>
                  <pub-id pub-id-type="doi">10.3390/ijms18030546</pub-id>
                  <?supplied-pmid 28273809?>
                  <pub-id pub-id-type="pmid">28273809</pub-id>
                </element-citation>
              </ref>
              <ref id="B18-ijms-19-02257">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Campbell</surname>
                      <given-names>J.J.</given-names>
                    </name>
                    <name>
                      <surname>Husmann</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Hume</surname>
                      <given-names>R.D.</given-names>
                    </name>
                    <name>
                      <surname>Watson</surname>
                      <given-names>C.J.</given-names>
                    </name>
                    <name>
                      <surname>Cameron</surname>
                      <given-names>R.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Development of three-dimensional collagen scaffolds with controlled architecture for cell migration studies using breast cancer cell lines</article-title>
                  <source>Biomaterials</source>
                  <year>2017</year>
                  <volume>114</volume>
                  <fpage>34</fpage>
                  <lpage>43</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.biomaterials.2016.10.048</pub-id>
                  <?supplied-pmid 27838472?>
                  <pub-id pub-id-type="pmid">27838472</pub-id>
                </element-citation>
              </ref>
              <ref id="B19-ijms-19-02257">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Aebersold</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Mass-spectrometric exploration of proteome structure and function</article-title>
                  <source>Nature</source>
                  <year>2016</year>
                  <volume>537</volume>
                  <fpage>347</fpage>
                  <lpage>355</lpage>
                  <pub-id pub-id-type="doi">10.1038/nature19949</pub-id>
                  <?supplied-pmid 27629641?>
                  <pub-id pub-id-type="pmid">27629641</pub-id>
                </element-citation>
              </ref>
              <ref id="B20-ijms-19-02257">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Kussian</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Sickmann</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Weber</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Nissum</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Westphal</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Egli</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Grosse</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Schönberger</surname>
                      <given-names>J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Application of free-flow IEF to identify protein candidates changing under microgravity conditions</article-title>
                  <source>Proteomics</source>
                  <year>2010</year>
                  <volume>10</volume>
                  <fpage>904</fpage>
                  <lpage>913</lpage>
                  <pub-id pub-id-type="doi">10.1002/pmic.200900226</pub-id>
                  <?supplied-pmid 20049858?>
                  <pub-id pub-id-type="pmid">20049858</pub-id>
                </element-citation>
              </ref>
              <ref id="B21-ijms-19-02257">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kononikhin</surname>
                      <given-names>A.S.</given-names>
                    </name>
                    <name>
                      <surname>Starodubtseva</surname>
                      <given-names>N.L.</given-names>
                    </name>
                    <name>
                      <surname>Pastushkova</surname>
                      <given-names>L.K.</given-names>
                    </name>
                    <name>
                      <surname>Kashirina</surname>
                      <given-names>D.N.</given-names>
                    </name>
                    <name>
                      <surname>Fedorchenko</surname>
                      <given-names>K.Y.</given-names>
                    </name>
                    <name>
                      <surname>Brhozovsky</surname>
                      <given-names>A.G.</given-names>
                    </name>
                    <name>
                      <surname>Popov</surname>
                      <given-names>I.A.</given-names>
                    </name>
                    <name>
                      <surname>Larina</surname>
                      <given-names>I.M.</given-names>
                    </name>
                    <name>
                      <surname>Nikolaev</surname>
                      <given-names>E.N.</given-names>
                    </name>
                  </person-group>
                  <article-title>Spaceflight induced changes in the human proteome</article-title>
                  <source>Expert Rev. Proteom.</source>
                  <year>2017</year>
                  <volume>14</volume>
                  <fpage>15</fpage>
                  <lpage>29</lpage>
                  <pub-id pub-id-type="doi">10.1080/14789450.2017.1258307</pub-id>
                  <?supplied-pmid 27817217?>
                  <pub-id pub-id-type="pmid">27817217</pub-id>
                </element-citation>
              </ref>
              <ref id="B22-ijms-19-02257">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>La Barbera</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Capriotti</surname>
                      <given-names>A.L.</given-names>
                    </name>
                    <name>
                      <surname>Michelini</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Piovesana</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Calabretta</surname>
                      <given-names>M.M.</given-names>
                    </name>
                    <name>
                      <surname>Zenezini Chiozzi</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Roda</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Lagana</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Proteomic analysis and bioluminescent reporter gene assays to investigate effects of simulated microgravity on caco-2 cells</article-title>
                  <source>Proteomics</source>
                  <year>2017</year>
                  <volume>17</volume>
                  <pub-id pub-id-type="doi">10.1002/pmic.201700081</pub-id>
                  <?supplied-pmid 28727291?>
                  <pub-id pub-id-type="pmid">28727291</pub-id>
                </element-citation>
              </ref>
              <ref id="B23-ijms-19-02257">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sahana</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Nassef</surname>
                      <given-names>M.Z.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Kopp</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Krüger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Corydon</surname>
                      <given-names>T.J.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Decreased e-cadherin in mcf7 human breast cancer cells forming multicellular spheroids exposed to simulated microgravity</article-title>
                  <source>Proteomics</source>
                  <year>2018</year>
                  <volume>18</volume>
                  <pub-id pub-id-type="doi">10.1002/pmic.201800015</pub-id>
                  <?supplied-pmid 29785723?>
                  <pub-id pub-id-type="pmid">29785723</pub-id>
                </element-citation>
              </ref>
              <ref id="B24-ijms-19-02257">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Riwaldt</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Sickmann</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Braun</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Segerer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Schwarzwälder</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Aleshcheva</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Corydon</surname>
                      <given-names>T.J.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Identification of proteins involved in inhibition of spheroid formation under microgravity</article-title>
                  <source>Proteomics</source>
                  <year>2015</year>
                  <volume>15</volume>
                  <fpage>2945</fpage>
                  <lpage>2952</lpage>
                  <pub-id pub-id-type="doi">10.1002/pmic.201500067</pub-id>
                  <?supplied-pmid 25930030?>
                  <pub-id pub-id-type="pmid">25930030</pub-id>
                </element-citation>
              </ref>
              <ref id="B25-ijms-19-02257">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grosse</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Schulz</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Saar</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Hübner</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Eilles</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Abou-El-Ardat</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Baatout</surname>
                      <given-names>S.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Gravity-sensitive signaling drives 3-dimensional formation of multicellular thyroid cancer spheroids</article-title>
                  <source>FASEB J.</source>
                  <year>2012</year>
                  <volume>26</volume>
                  <fpage>5124</fpage>
                  <lpage>5140</lpage>
                  <pub-id pub-id-type="doi">10.1096/fj.12-215749</pub-id>
                  <?supplied-pmid 22964303?>
                  <pub-id pub-id-type="pmid">22964303</pub-id>
                </element-citation>
              </ref>
              <ref id="B26-ijms-19-02257">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Sickmann</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Weber</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Annotated gene and proteome data support recognition of interconnections between the results of different experiments in space research</article-title>
                  <source>Microgravity Sci. Technol.</source>
                  <year>2016</year>
                  <volume>28</volume>
                  <fpage>357</fpage>
                  <lpage>365</lpage>
                  <pub-id pub-id-type="doi">10.1007/s12217-015-9451-z</pub-id>
                </element-citation>
              </ref>
              <ref id="B27-ijms-19-02257">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Paulsen</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Thiel</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Timm</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Schmidt</surname>
                      <given-names>P.M.</given-names>
                    </name>
                    <name>
                      <surname>Huber</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Tauber</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Hemmersbach</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Seibt</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Kroll</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Grote</surname>
                      <given-names>K.-H.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Microgravity-induced alterations in signal transduction in cells of the immune system</article-title>
                  <source>Acta Astronaut.</source>
                  <year>2010</year>
                  <volume>67</volume>
                  <fpage>1116</fpage>
                  <lpage>1125</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.actaastro.2010.06.053</pub-id>
                </element-citation>
              </ref>
              <ref id="B28-ijms-19-02257">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Xu</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Ding</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Tan</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Actin cytoskeleton mediates BMP2-Smad signaling via calponin 1 in preosteoblast under simulated microgravity</article-title>
                  <source>Biochimie</source>
                  <year>2017</year>
                  <volume>138</volume>
                  <fpage>184</fpage>
                  <lpage>193</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.biochi.2017.04.015</pub-id>
                  <?supplied-pmid 28457943?>
                  <pub-id pub-id-type="pmid">28457943</pub-id>
                </element-citation>
              </ref>
              <ref id="B29-ijms-19-02257">
                <label>29.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Krishna</surname>
                      <given-names>R.G.</given-names>
                    </name>
                    <name>
                      <surname>Wold</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Post-translational modifications of proteins</article-title>
                  <source>Methods in Protein Sequence Analysis</source>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Imahori</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Sakiyama</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <publisher-name>Springer</publisher-name>
                  <publisher-loc>Boston, MA, USA</publisher-loc>
                  <year>1993</year>
                  <fpage>167</fpage>
                  <lpage>172</lpage>
                </element-citation>
              </ref>
              <ref id="B30-ijms-19-02257">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kessler</surname>
                      <given-names>B.M.</given-names>
                    </name>
                    <name>
                      <surname>Edelmann</surname>
                      <given-names>M.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>PTMs in conversation: Activity and function of deubiquitinating enzymes regulated via post-translational modifications</article-title>
                  <source>Cell Biochem. Biophys.</source>
                  <year>2011</year>
                  <volume>60</volume>
                  <fpage>21</fpage>
                  <lpage>38</lpage>
                  <pub-id pub-id-type="doi">10.1007/s12013-011-9176-6</pub-id>
                  <?supplied-pmid 21480003?>
                  <pub-id pub-id-type="pmid">21480003</pub-id>
                </element-citation>
              </ref>
              <ref id="B31-ijms-19-02257">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Khoury</surname>
                      <given-names>G.A.</given-names>
                    </name>
                    <name>
                      <surname>Baliban</surname>
                      <given-names>R.C.</given-names>
                    </name>
                    <name>
                      <surname>Floudas</surname>
                      <given-names>C.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Proteome-wide post-translational modification statistics: Frequency analysis and curation of the swiss-prot database</article-title>
                  <source>Sci. Rep.</source>
                  <year>2011</year>
                  <volume>1</volume>
                  <pub-id pub-id-type="doi">10.1038/srep00090</pub-id>
                  <?supplied-pmid 22034591?>
                  <pub-id pub-id-type="pmid">22034591</pub-id>
                </element-citation>
              </ref>
              <ref id="B32-ijms-19-02257">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Csizmok</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Forman-Kay</surname>
                      <given-names>J.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Complex regulatory mechanisms mediated by the interplay of multiple post-translational modifications</article-title>
                  <source>Curr. Opin. Struct. Biol.</source>
                  <year>2018</year>
                  <volume>48</volume>
                  <fpage>58</fpage>
                  <lpage>67</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.sbi.2017.10.013</pub-id>
                  <?supplied-pmid 29100108?>
                  <pub-id pub-id-type="pmid">29100108</pub-id>
                </element-citation>
              </ref>
              <ref id="B33-ijms-19-02257">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Huang</surname>
                      <given-names>K.Y.</given-names>
                    </name>
                    <name>
                      <surname>Su</surname>
                      <given-names>M.G.</given-names>
                    </name>
                    <name>
                      <surname>Kao</surname>
                      <given-names>H.J.</given-names>
                    </name>
                    <name>
                      <surname>Hsieh</surname>
                      <given-names>Y.C.</given-names>
                    </name>
                    <name>
                      <surname>Jhong</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Cheng</surname>
                      <given-names>K.H.</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>H.D.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>T.Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>dbPTM 2016: 10-year anniversary of a resource for post-translational modification of proteins</article-title>
                  <source>Nucleic Acids Res.</source>
                  <year>2016</year>
                  <volume>44</volume>
                  <fpage>D435</fpage>
                  <lpage>D446</lpage>
                  <pub-id pub-id-type="doi">10.1093/nar/gkv1240</pub-id>
                  <?supplied-pmid 26578568?>
                  <pub-id pub-id-type="pmid">26578568</pub-id>
                </element-citation>
              </ref>
              <ref id="B34-ijms-19-02257">
                <label>34.</label>
                <element-citation publication-type="confproc">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gombocz</surname>
                      <given-names>E.A.</given-names>
                    </name>
                    <name>
                      <surname>Stanley</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <name>
                      <surname>Rockey</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Nishimura</surname>
                      <given-names>T.</given-names>
                    </name>
                  </person-group>
                  <article-title>Data integration framework for discovery and validation: Smart merging of experimental and public data across ontologies and taxonomies</article-title>
                  <source>Proceedings of the Bio-IT World</source>
                  <conf-loc>Boston, MA, USA</conf-loc>
                  <conf-date>15–17 May 2008</conf-date>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.io-informatics.com/news/pdfs/CHI_BioIT2008_poster1.pdf">http://www. io-informatics.com/news/pdfs/CHI_BioIT2008_poster1.pdf</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2017-07-17">(accessed on 17 July 2017)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B35-ijms-19-02257">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Gombocz</surname>
                      <given-names>E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Semantic analysis of thyroid cancer cell proteins obtained from rare research opportunities</article-title>
                  <source>J. Biomed. Inform.</source>
                  <year>2017</year>
                  <volume>76</volume>
                  <fpage>138</fpage>
                  <lpage>153</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jbi.2017.10.011</pub-id>
                  <?supplied-pmid 29054708?>
                  <pub-id pub-id-type="pmid">29054708</pub-id>
                </element-citation>
              </ref>
              <ref id="B36-ijms-19-02257">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Guo</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Wen</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Duan</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>An</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Shi</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>The modest impact of transcription factor Nrf2 on the course of disease in an ALS animal model</article-title>
                  <source>Lab. Investig.</source>
                  <year>2013</year>
                  <volume>93</volume>
                  <fpage>825</fpage>
                  <lpage>833</lpage>
                  <pub-id pub-id-type="doi">10.1038/labinvest.2013.73</pub-id>
                  <?supplied-pmid 23711824?>
                  <pub-id pub-id-type="pmid">23711824</pub-id>
                </element-citation>
              </ref>
              <ref id="B37-ijms-19-02257">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kopp</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Sahana</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Islam</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Petersen</surname>
                      <given-names>A.G.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Corydon</surname>
                      <given-names>T.J.</given-names>
                    </name>
                    <name>
                      <surname>Schulz</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Saar</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Huebner</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Slumstrup</surname>
                      <given-names>L.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The role of nfkappab in spheroid formation of human breast cancer cells cultured on the random positioning machine</article-title>
                  <source>Sci. Rep.</source>
                  <year>2018</year>
                  <volume>8</volume>
                  <pub-id pub-id-type="doi">10.1038/s41598-017-18556-8</pub-id>
                  <?supplied-pmid 29343717?>
                  <pub-id pub-id-type="pmid">29343717</pub-id>
                </element-citation>
              </ref>
              <ref id="B38-ijms-19-02257">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Warnke</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Görög</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Hemmersbach</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Braun</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Sahana</surname>
                      <given-names>J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Spheroid formation of human thyroid cancer cells under simulated microgravity: A possible role of CTGF and CAV1</article-title>
                  <source>Cell Commun. Signal.</source>
                  <year>2014</year>
                  <volume>12</volume>
                  <pub-id pub-id-type="doi">10.1186/1478-811X-12-32</pub-id>
                  <?supplied-pmid 24885050?>
                  <pub-id pub-id-type="pmid">24885050</pub-id>
                </element-citation>
              </ref>
              <ref id="B39-ijms-19-02257">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dittrich</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Sahana</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Krüger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Magnusson</surname>
                      <given-names>N.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Key proteins involved in spheroid formation and angiogenesis in endothelial cells after long-term exposure to simulated microgravity</article-title>
                  <source>Cell Physiol. Biochem.</source>
                  <year>2018</year>
                  <volume>45</volume>
                  <fpage>429</fpage>
                  <lpage>445</lpage>
                  <pub-id pub-id-type="doi">10.1159/000486920</pub-id>
                  <?supplied-pmid 29402845?>
                  <pub-id pub-id-type="pmid">29402845</pub-id>
                </element-citation>
              </ref>
              <ref id="B40-ijms-19-02257">
                <label>40.</label>
                <element-citation publication-type="web">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Harris</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Seaborne</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Prud’hommeaux</surname>
                      <given-names>E.</given-names>
                    </name>
                  </person-group>
                  <article-title>W3c Recommendation 21 March 2013</article-title>
                  <comment>SPARQL 1.1 Query Language 2013</comment>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.w3.org/TR/2013/REC-sparql11-query-20130321/">http://www.w3.org/TR/2013/REC-sparql11-query-20130321/</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2017-07-17">(accessed on 17 July 2017)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B41-ijms-19-02257">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Boutet</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Lieberherr</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Tognolli</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Schneider</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bansal</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Bridge</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>Poux</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Bougueleret</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Xenarios</surname>
                      <given-names>I.</given-names>
                    </name>
                  </person-group>
                  <article-title>Uniprotkb/swiss-prot, the manually annotated section of the uniprot knowledgebase: How to use the entry view</article-title>
                  <source>Methods Mol. Biol.</source>
                  <year>2016</year>
                  <volume>1374</volume>
                  <fpage>23</fpage>
                  <lpage>54</lpage>
                  <?supplied-pmid 26519399?>
                  <pub-id pub-id-type="pmid">26519399</pub-id>
                </element-citation>
              </ref>
              <ref id="B42-ijms-19-02257">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lindberg</surname>
                      <given-names>D.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Internet access to the national library of medicine</article-title>
                  <source>Eff. Clin. Pract.</source>
                  <year>2000</year>
                  <volume>3</volume>
                  <fpage>256</fpage>
                  <lpage>260</lpage>
                  <?supplied-pmid 11185333?>
                  <pub-id pub-id-type="pmid">11185333</pub-id>
                </element-citation>
              </ref>
              <ref id="B43-ijms-19-02257">
                <label>43.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hassanzadeh</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>R.J.</given-names>
                    </name>
                  </person-group>
                  <source>Automatic Curation of Clinical Trials Data in Linkedct CT</source>
                  <publisher-name>Springer International Publishing</publisher-name>
                  <publisher-loc>Cham, Switzerland</publisher-loc>
                  <year>2015</year>
                  <fpage>270</fpage>
                  <lpage>278</lpage>
                </element-citation>
              </ref>
              <ref id="B44-ijms-19-02257">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Milacic</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Haw</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Rothfels</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Croft</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Hermjakob</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>D’Eustachio</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Stein</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Annotating cancer variants and anti-cancer therapeutics in reactome</article-title>
                  <source>Cancers</source>
                  <year>2012</year>
                  <volume>4</volume>
                  <fpage>1180</fpage>
                  <lpage>1211</lpage>
                  <pub-id pub-id-type="doi">10.3390/cancers4041180</pub-id>
                  <?supplied-pmid 24213504?>
                  <pub-id pub-id-type="pmid">24213504</pub-id>
                </element-citation>
              </ref>
              <ref id="B45-ijms-19-02257">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Romero-Chapman</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Tinker</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Uriu-Hare</surname>
                      <given-names>J.Y.</given-names>
                    </name>
                    <name>
                      <surname>Keen</surname>
                      <given-names>C.L.</given-names>
                    </name>
                    <name>
                      <surname>Rucker</surname>
                      <given-names>R.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Purification, properties and influence of dietary copper on accumulation and functional activity of lysyl oxidase in rat skin</article-title>
                  <source>Biochem. J.</source>
                  <year>1991</year>
                  <volume>275</volume>
                  <issue-part>Pt 3</issue-part>
                  <fpage>657</fpage>
                  <lpage>662</lpage>
                  <pub-id pub-id-type="doi">10.1042/bj2750657</pub-id>
                  <?supplied-pmid 1674861?>
                  <pub-id pub-id-type="pmid">1674861</pub-id>
                </element-citation>
              </ref>
              <ref id="B46-ijms-19-02257">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bekker-Jensen</surname>
                      <given-names>D.B.</given-names>
                    </name>
                    <name>
                      <surname>Kelstrup</surname>
                      <given-names>C.D.</given-names>
                    </name>
                    <name>
                      <surname>Batth</surname>
                      <given-names>T.S.</given-names>
                    </name>
                    <name>
                      <surname>Larsen</surname>
                      <given-names>S.C.</given-names>
                    </name>
                    <name>
                      <surname>Haldrup</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Bramsen</surname>
                      <given-names>J.B.</given-names>
                    </name>
                    <name>
                      <surname>Sørensen</surname>
                      <given-names>K.D.</given-names>
                    </name>
                    <name>
                      <surname>Høyer</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Ørntoft</surname>
                      <given-names>T.F.</given-names>
                    </name>
                    <name>
                      <surname>Andersen</surname>
                      <given-names>C.L.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>An optimized shotgun strategy for the rapid generation of comprehensive human proteomes</article-title>
                  <source>Cell Syst.</source>
                  <year>2017</year>
                  <volume>4</volume>
                  <fpage>587</fpage>
                  <lpage>599.e4</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.cels.2017.05.009</pub-id>
                  <?supplied-pmid 28601559?>
                  <pub-id pub-id-type="pmid">28601559</pub-id>
                </element-citation>
              </ref>
              <ref id="B47-ijms-19-02257">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rappsilber</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Ishihama</surname>
                      <given-names>Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using stagetips</article-title>
                  <source>Nat. Protoc.</source>
                  <year>2007</year>
                  <volume>2</volume>
                  <fpage>1896</fpage>
                  <lpage>1906</lpage>
                  <pub-id pub-id-type="doi">10.1038/nprot.2007.261</pub-id>
                  <?supplied-pmid 17703201?>
                  <pub-id pub-id-type="pmid">17703201</pub-id>
                </element-citation>
              </ref>
              <ref id="B48-ijms-19-02257">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nagaraj</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Kulak</surname>
                      <given-names>N.A.</given-names>
                    </name>
                    <name>
                      <surname>Cox</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Neuhauser</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Mayr</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Hoerning</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Vorm</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>System-wide perturbation analysis with nearly complete coverage of the yeast proteome by single-shot ultra hplc runs on a bench top orbitrap</article-title>
                  <source>Mol. Cell. Proteom.</source>
                  <year>2012</year>
                  <volume>11</volume>
                  <pub-id pub-id-type="doi">10.1074/mcp.M111.013722</pub-id>
                  <?supplied-pmid 22021278?>
                  <pub-id pub-id-type="pmid">22021278</pub-id>
                </element-citation>
              </ref>
              <ref id="B49-ijms-19-02257">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cox</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Maxquant enables high peptide identification rates, individualized p.P.B.-range mass accuracies and proteome-wide protein quantification</article-title>
                  <source>Nat. Biotechnol.</source>
                  <year>2008</year>
                  <volume>26</volume>
                  <fpage>1367</fpage>
                  <lpage>1372</lpage>
                  <pub-id pub-id-type="doi">10.1038/nbt.1511</pub-id>
                  <?supplied-pmid 19029910?>
                  <pub-id pub-id-type="pmid">19029910</pub-id>
                </element-citation>
              </ref>
              <ref id="B50-ijms-19-02257">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cox</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Hein</surname>
                      <given-names>M.Y.</given-names>
                    </name>
                    <name>
                      <surname>Luber</surname>
                      <given-names>C.A.</given-names>
                    </name>
                    <name>
                      <surname>Paron</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Nagaraj</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed maxlfq</article-title>
                  <source>Mol. Cell. Proteom.</source>
                  <year>2014</year>
                  <volume>13</volume>
                  <fpage>2513</fpage>
                  <lpage>2526</lpage>
                  <pub-id pub-id-type="doi">10.1074/mcp.M113.031591</pub-id>
                  <?supplied-pmid 24942700?>
                  <pub-id pub-id-type="pmid">24942700</pub-id>
                </element-citation>
              </ref>
              <ref id="B51-ijms-19-02257">
                <label>51.</label>
                <element-citation publication-type="gov">
                  <article-title>National Center for Biotechnology Information</article-title>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2018-08-01">(accessed on 1 August 2018)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B52-ijms-19-02257">
                <label>52.</label>
                <element-citation publication-type="web">
                  <article-title>dbPTM</article-title>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://dbptm.mbc.nctu.edu.tw/">http://dbptm.mbc.nctu.edu.tw/</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2018-08-01">(accessed on 1 August 2018)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B53-ijms-19-02257">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Breitwieser</surname>
                      <given-names>F.P.</given-names>
                    </name>
                    <name>
                      <surname>Colinge</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>IsobarPTM: A software tool for the quantitative analysis of post-translationally modified proteins</article-title>
                  <source>J. Proteom.</source>
                  <year>2013</year>
                  <volume>90</volume>
                  <fpage>77</fpage>
                  <lpage>84</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jprot.2013.02.022</pub-id>
                  <?supplied-pmid 23470796?>
                  <pub-id pub-id-type="pmid">23470796</pub-id>
                </element-citation>
              </ref>
              <ref id="B54-ijms-19-02257">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Jia</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Yu</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Sun</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>He</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Lv</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Glocker</surname>
                      <given-names>M.O.</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>L.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Sysptm 2.0: An updated systematic resource for post-translational modification</article-title>
                  <source>Database</source>
                  <year>2014</year>
                  <volume>2014</volume>
                  <pub-id pub-id-type="doi">10.1093/database/bau025</pub-id>
                  <?supplied-pmid 24705204?>
                  <pub-id pub-id-type="pmid">24705204</pub-id>
                </element-citation>
              </ref>
              <ref id="B55-ijms-19-02257">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>Y.J.</given-names>
                    </name>
                    <name>
                      <surname>Lu</surname>
                      <given-names>C.T.</given-names>
                    </name>
                    <name>
                      <surname>Su</surname>
                      <given-names>M.G.</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>K.Y.</given-names>
                    </name>
                    <name>
                      <surname>Ching</surname>
                      <given-names>W.C.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>H.H.</given-names>
                    </name>
                    <name>
                      <surname>Liao</surname>
                      <given-names>Y.C.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>Y.J.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>T.Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>Dbsno 2.0: A resource for exploring structural environment, functional and disease association and regulatory network of protein s-nitrosylation</article-title>
                  <source>Nucleic Acids Res.</source>
                  <year>2015</year>
                  <volume>43</volume>
                  <fpage>D503</fpage>
                  <lpage>D511</lpage>
                  <pub-id pub-id-type="doi">10.1093/nar/gku1176</pub-id>
                  <?supplied-pmid 25399423?>
                  <pub-id pub-id-type="pmid">25399423</pub-id>
                </element-citation>
              </ref>
              <ref id="B56-ijms-19-02257">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Spasić</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Dunn</surname>
                      <given-names>W.B.</given-names>
                    </name>
                    <name>
                      <surname>Velarde</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Tseng</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Jenkins</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Hardy</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Oliver</surname>
                      <given-names>S.G.</given-names>
                    </name>
                    <name>
                      <surname>Kell</surname>
                      <given-names>D.B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Memo: A hybrid sql/xml approach to metabolomic data management for functional genomics</article-title>
                  <source>BMC Bioinform.</source>
                  <year>2006</year>
                  <volume>7</volume>
                  <pub-id pub-id-type="doi">10.1186/1471-2105-7-281</pub-id>
                  <?supplied-pmid 16753052?>
                  <pub-id pub-id-type="pmid">16753052</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig id="ijms-19-02257-f001" orientation="portrait" position="float">
              <label>Figure 1</label>
              <caption>
                <p>Localization of the selected proteins and their interactions on gene and protein levels. Blue circle indicates nucleus, yellow figure indicates endoplasmatic reticulum, orange shows the mitochondrion and ocher the Golgi apparatus. Solid lines indicate binding, solid arrows indicate regulation by direct interaction, dashed arrows indicate indirect regulation via other cellular components. Green arrows indicate up-regulation, red arrows indicate down-regulation.</p>
              </caption>
              <graphic xlink:href="ijms-19-02257-g001"/>
            </fig>
            <fig id="ijms-19-02257-f002" orientation="portrait" position="float">
              <label>Figure 2</label>
              <caption>
                <p>Databases, with their partially extended ontological class trees, whose content was searched via Semantic Protocol and RDF Query Language (SPARQL) using Knowledge Explorer (KE) [<xref rid="B34-ijms-19-02257" ref-type="bibr">34</xref>,<xref rid="B40-ijms-19-02257" ref-type="bibr">40</xref>]. Retrieved results were imported, harmonized and mapped to this ontology to create a Semantic Knowledge Base.</p>
              </caption>
              <graphic xlink:href="ijms-19-02257-g002"/>
            </fig>
            <fig id="ijms-19-02257-f003" orientation="portrait" position="float">
              <label>Figure 3</label>
              <caption>
                <p>Uniprot derived starting network for heme oxygenase 1 and NAD(P)H dehydrogenase [quinone] 1. The network includes data about the proteins’ names and accession numbers, about enzyme classes, as well as about posttranslational modifications (PTMs) stored in UniProt [<xref rid="B31-ijms-19-02257" ref-type="bibr">31</xref>]. Similar information was gathered for all the other proteins.</p>
              </caption>
              <graphic xlink:href="ijms-19-02257-g003"/>
            </fig>
            <fig id="ijms-19-02257-f004" orientation="portrait" position="float">
              <label>Figure 4</label>
              <caption>
                <p>Results of a KE-mediated comprehensive search for information about HMOX-1 in UniProt, NLM-reference databases, and Reactome. The upper half shows NCBI Entrez data about HMOX1 restricted to thyroid (left to right: OMIM, Biosystems, Pubmed—violet blue); the lower left to center shows UniProt data (brown). On the right of the center line are classified PTMs (yellow-green) from dbPTM with their reference resources attached (light blue). (This is a high-resolution picture. A reader interested in detail may zoom in to amplify.).</p>
              </caption>
              <graphic xlink:href="ijms-19-02257-g004"/>
            </fig>
            <fig id="ijms-19-02257-f005" orientation="portrait" position="float">
              <label>Figure 5</label>
              <caption>
                <p>A typical graphical SPARQL query for searching for information about all proteins imported in the KE via a spreadsheet in databases of interest for the topic of a study (see also ref. [<xref rid="B35-ijms-19-02257" ref-type="bibr">35</xref>]). The query shown directs KE to the dbPTM to search for substrate sites and location of modifications, as well as for the surface area covered by the modification (<bold>a</bold>). The graphical query is auto-translated into a SPARQL text query by KE and used for searches (<bold>b</bold>).</p>
              </caption>
              <graphic xlink:href="ijms-19-02257-g005a"/>
              <graphic xlink:href="ijms-19-02257-g005b"/>
            </fig>
            <fig id="ijms-19-02257-f006" orientation="portrait" position="float">
              <label>Figure 6</label>
              <caption>
                <p>Overview of PTMs (yellow-green boxes) of 23 of the selected proteins (icons with accession numbers). The arrows indicate the relationship between a protein and a PTM.</p>
              </caption>
              <graphic xlink:href="ijms-19-02257-g006"/>
            </fig>
            <table-wrap id="ijms-19-02257-t001" orientation="portrait" position="float">
              <object-id pub-id-type="pii">ijms-19-02257-t001_Table 1</object-id>
              <label>Table 1</label>
              <caption>
                <p>List of 69 selected proteins that were imported into the Knowledge Explorer, with protein names, gene names, accession numbers and LfQs * obtained for proteins of FTC-133 cells, before it was used for searching UniProt. LfQ * values for MCF-7 cells are given for comparison.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="2" colspan="1"> Gene Name</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="2" colspan="1"> Protein Name with Swiss Prot Accession Number</th>
                    <th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">FTC-133</th>
                    <th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">MCF-7</th>
                  </tr>
                  <tr>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LfQ * [1<italic>g</italic>]</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LfQ * [µ<italic>g</italic>]</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LfQ * [1<italic>g</italic>]</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LfQ * [µ<italic>g</italic>]</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>RAB27B</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ras-related protein Rab-27B (O00194)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.11</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.24</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.81</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>XPOT</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exportin-T (O43592)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.75</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.62</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.92</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>NMT2</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycylpeptide <italic>N</italic>-tetradecanoyltransferase 2 (O60551)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.31</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.39</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.72</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>FUCA1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tissue alpha-<sc>l</sc>-fucosidase (P04066)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.02</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.32</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.95</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>THBS1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thrombospondin-1 (P07996)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.96</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.89</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.1</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>IGFBP2</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Insulin-like growth factor-binding protein 2 (P18065)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.25</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.92</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.85</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>CBL</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E3 ubiquitin-protein ligase CBL (P22681)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.74</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.12</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.23</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>UBE2D1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ubiquitin-conjugating enzyme E2 D1 (P51668)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.49</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.14</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>USP11</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ubiquitin carboxyl-terminal hydrolase 11 (P51784)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.98</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.27</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.56</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>BLOC1S1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biogenesis of lysosome-related organelles complex 1 subunit 1 (P78537)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.82</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.45</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>GALK2</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>N</italic>-acetylgalactosamine kinase (Q01415)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.61</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.82</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>TP53I3</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quinone oxidoreductase PIG3 (Q53FA7)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.52</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.41</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.77</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>ZFYVE26</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zinc finger FYVE domain-containing protein 26 (Q68DK2)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.22</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.05</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.16</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>C3orf17</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Uncharacterized protein C3orf17 (Q6NW34)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.01</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.05</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.25</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>FASTKD5</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FAST kinase domain-containing protein 5 (Q7L8L6)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.02</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.46</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>HS2ST1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Heparan sulfate 2-<sc>O</sc>-sulfotransferase 1 (Q7LGA3)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.13</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.37</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>SZRD1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SUZ domain-containing protein 1 (Q7Z422)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.52</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.24</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>UBE2Q1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ubiquitin-conjugating enzyme E2 Q1 (Q7Z7E8)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.64</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.21</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.94</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>SYVN1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E3 ubiquitin-protein ligase synoviolin (Q86TM6)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.69</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.09</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.39</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>SLC35B2</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adenosine 3-phospho 5-phosphosulfate transporter 1 (Q8TB61)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.82</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.97</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.42</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>NEK9</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serine/threonine-protein kinase Nek9 (Q8TD19)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.38</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.86</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.75</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>CHMP7</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Charged multivesicular body protein 7 (Q8WUX9)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.98</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.92</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>GTF3C6</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">General transcription factor 3C polypeptide 6 (Q969F1)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.97</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.37</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.79</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>AIDA</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Axin interactor. dorsalization-associated protein (Q96BJ3)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.91</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.17</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>GPATCH1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G patch domain-containing protein 1 (Q9BRR8)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.77</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.13</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>ADI1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2-dihydroxy-3-keto-5-methylthiopentene dioxygenase (Q9BV57)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.32</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.08</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29.15</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>DUSP23</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dual specificity protein phosphatase 23 (Q9BVJ7)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.75</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.76</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.02</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>C20orf27</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UPF0687 protein C20orf27 (Q9GZN8)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.05</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.55</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.08</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>DNAJC5</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DnaJ homolog subfamily C member 5 (Q9H3Z4)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.84</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.88</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.6</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>CBX8</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chromobox protein homolog 8 (Q9HC52)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.35</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.79</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.86</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>BIN3</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bridging integrator 3 (Q9NQY0)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.34</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.27</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>TBC1D13</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TBC1 domain family member 13 (Q9NVG8)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.6</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.59</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.98</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>IGBP1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immunoglobulin-binding protein 1 (P78318)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.7</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.32</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.14</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.33</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>ANKRD52</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (Q8NB46)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.73</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.37</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.18</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>THOP1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thimet oligopeptidase (P52888)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.04</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.05</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.58</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.49</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>AGPAT9</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycerol-3-phosphate acyltransferase 3 (Q53EU6)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.25</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.46</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.13</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>HBA2</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hemoglobin subunit alpha (G3V1N2)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.43</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.92</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.05</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.25</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>UBE2D3</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ubiquitin-conjugating enzyme E2 D3 (P61077)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.6</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.05</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.26</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>GM2A</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ganglioside GM2 activator (P48637)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.75</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.34</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.12</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.45</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>KDM2A</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lysine-specific demethylase 2A (Q9Y2K7)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.87</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.59</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.47</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.13</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>GSS</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glutathione synthetase (P48637)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.89</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.08</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.14</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.99</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>TMEM263</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Transmembrane protein 263 (Q8WUH6)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.29</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.19</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.66</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.68</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>BRD2</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bromodomain-containing protein 2 (P25440)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.33</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.43</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.15</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.39</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>GCLM</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glutamate-cysteine ligase regulatory subunit (P48507)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.91</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.31</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.30</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.93</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>PPP5C</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serine/threonine-protein phosphatase 5 (P53041)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.99</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.22</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.96</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.77</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>PTGR1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prostaglandin reductase 1 (Q14914)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.25</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.92</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.21</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.62</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>PIN4</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 (Q9Y237)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.59</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.75</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.64</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.88</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>TXNDC17</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thioredoxin domain-containing protein 17 (Q9BRA2)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.88</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.58</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.38</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.39</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>PSMB3</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Proteasome subunit beta type-3 (P49720)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.92</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.72</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.05</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.5</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>HSP90AB2P</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Putative heat shock protein HSP 90-beta 2 (Q58FF8)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.19</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.49</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.79</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.46</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>DDT</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D-dopachrome decarboxylase (P30046)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.46</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.31</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.35</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.21</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>OSTF1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Osteoclast-stimulating factor 1 (Q92882)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.47</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.57</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.97</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.56</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>UFM1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ubiquitin-fold modifier 1 (P61960)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.89</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.94</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.82</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.55</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>APOB</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Apolipoprotein B-100 (P04114)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.67</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.51</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.10</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.18</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>CRABP2</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cellular retinoic acid-binding protein 2 (P29373)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.88</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.32</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.46</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">65.46</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>PSMA1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Proteasome subunit alpha type-1 (P25786)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.84</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.82</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.4</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.7</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>HMOX1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Heme oxygenase 1 (P09601)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.62</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">108.19</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.58</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.39</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>COPB1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Coatomer subunit beta (P53618)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.3</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83.81</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">122.1</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>CKB</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Creatine kinase B-type (P12277)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21.21</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.3</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.72</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.35</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>NQO1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NAD(P)H dehydrogenase [quinone] 1 (P15559)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.76</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.44</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">65.66</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">183.6</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>PSMA6</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Proteasome subunit alpha type-6 (P60900)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.4</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.27</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.53</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.56</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>TPT1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Translationally-controlled tumor protein (P13693)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.04</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64.58</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.01</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35.49</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>DSTN</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Destrin (P60981)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79.13</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.27</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34.58</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>TXN</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thioredoxin (P10599)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34.2</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">88.24</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">209.2</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">431.8</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>COPB2</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Coatomer subunit beta (P35606)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55.33</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">102.36</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">57.34</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">107.4</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>STIP1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stress-induced-phosphoprotein 1 (P31948)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80.66</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">186.81</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">123</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">208.2</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>PFN1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Profilin-1 (P07737)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">89.96</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">221.3</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">126.1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">265.1</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>NSF</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vesicle-fusing ATPase (P46459)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93.46</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">206.55</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41.33</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">76.3</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic>CFL1</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cofilin-1 (P23528)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">150.6</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">316.26</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">238.9</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">628.9</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>* LfQ (label free quantitation) are scores given * 10<sup>8</sup>; FTC-133 LfQ, proteins were derived from FTC-133 cells.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap id="ijms-19-02257-t002" orientation="portrait" position="float">
              <object-id pub-id-type="pii">ijms-19-02257-t002_Table 2</object-id>
              <label>Table 2</label>
              <caption>
                <p>Five exemplary proteins and their PTMs with location and short sequences before and after a modified site.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene Name</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Modification</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Location</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Substrate Site</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>RAB27B</italic> (O00194)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>N</italic>-acetylthreonine</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MTDGDY</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>XPOT</italic> (O43592)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>N</italic>-acetylmelthionine</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDEQA</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">557</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KSLNKQMNP</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>N</italic>6-acetyllysine</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">627</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PLMEKFKIL</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">629</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MEKFKILLE</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">634</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ILLEKLMLA</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>N</italic>6-acetyllysine</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">634</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ILLEKLMLA</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phosphothreonine</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">661</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FASRTSKAF</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>GM2A</italic> (P17900)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S</italic>-cysteinyl 3-(oxidosulfanyl)alanine (Cys-Cys)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SWDNCDEGK</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>N</italic>-linked (GlcNAc)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">63</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IVPGNVTLS</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S</italic>-cysteinyl 3-(oxidosulfanyl)alanine (Cys-Cys)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IKIPCTDYI</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S</italic>-cysteinyl 3-(oxidosulfanyl)alanine (Cys-Cys)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">106</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">YIGSCTFEH</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S</italic>-cysteinyl 3-(oxidosulfanyl)alanine (Cys-Cys)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">112</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FEHFCDVLD</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S</italic>-cysteinyl 3-(oxidosulfanyl)alanine (Cys-Cys)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">125</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TGEPCPEPL</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S</italic>-cysteinyl 3-(oxidosulfanyl)alanine (Cys-Cys)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">136</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">YGLPCHCPF</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S</italic>-cysteinyl 3-(oxidosulfanyl)alanine (Cys-Cys)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">138</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LPCHCPFKE</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S</italic>-cysteinyl 3-(oxidosulfanyl)alanine (Cys-Cys)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">183</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KRLGCIKIA</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>THBS1</italic> (P07996)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>N</italic>-linked (GlcNAc)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">248</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NNVVNGSSP</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C</italic>-linked (Man)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">385</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GWSPWSEWT</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>O</italic>-linked (Fuc)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">394</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SCSTSCGNG</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>O</italic>-linked (GalNAc)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">394</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SCSTSCGNG</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C</italic>-linked (Man)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">438</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">QDGGWSHWS</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C</italic>-linked (Man)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">441</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GWSHWSPWS</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S</italic>-cysteinyl 3-(oxidosulfanyl)alanine (Cys-Cys)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">447</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PWSSCSVTC</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>O</italic>-linked (Fuc)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">450</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SCSVTCGDG</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>O</italic>-linked (GalNAc)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">450</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SCSVTCGDG</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S</italic>-cysteinyl 3-(oxidosulfanyl)alanine (Cys-Cys)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">451</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CSVTCGDGV</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S</italic>-cysteinyl 3-(oxidosulfanyl)alanine (Cys-Cys)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">462</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RIRLCNSPS</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S</italic>-cysteinyl 3-(oxidosulfanyl)alanine (Cys-Cys)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">474</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NGKPCEGEA</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S</italic>-cysteinyl 3-(oxidosulfanyl)alanine (Cys-Cys)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">484</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ETKACKKDA</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S</italic>-cysteinyl 3-(oxidosulfanyl)alanine (Cys-Cys)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">489</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KKDACPING</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C</italic>-linked (Man)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">498</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GWGPWSPWD</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>O</italic>-linked (Fuc)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">507</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ICSVTCGGG</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>N</italic>-linked (GlcNAc)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1067</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VKVVNSTTG</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>PSMA1</italic> (P25786)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>N</italic>-acetylmethionine</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MFRNQ</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phosphoserine</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VTVWSPQGR</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MEAVKQGSA</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">YTVGLKSKTH</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GLKSKTHAV</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phosphoserine</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">54</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KRAQSELAA</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">61</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AAHQKKILH</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">115</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LIGSKTQIP</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">208</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DLTTKNVSI</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phosphoserine</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">211</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TKNVSIGIV</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">243</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RPQRKAQPA</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">256</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EPAEKADEP</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
